Brief report: disseminated mycobacteriosis caused by drug-resistant Mycobacterium triplex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy.
Mycobacterium triplex is a novel species that, until now, has been isolated only from limited clinical samples, and its clinical relevance has been largely unknown. In this report, we describe the first case of disseminated disease caused by M. triplex in a human immunodeficiency virus-infected patient.
Cingolani
A
A
Department of Infectious Diseases, Catholic University, L.go A. Gemelli, 8-00168 Rome, Italy. antonella.cingolani@tin.it
Sanguinetti
M
M
Antinori
A
A
Larocca
L M
LM
Ardito
F
F
Posteraro
B
B
Federico
G
G
Fadda
G
G
Ortona
L
L
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009161:Mycobacterium / Q000187:drug effects*; D009164:Mycobacterium Infections / Q000150:complications / Q000382:microbiology*
D019380:Anti-HIV Agents; D000995:Antitubercular Agents